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A Case of Rectal Squamous Cell Carcinoma with 
Metachronous Diffuse Large B Cell Lymphoma in an 
HIV-Infected Patient
Heun Choi1, Hye Won Lee1, Hea Won Ann1, Jae Kyung Kim1, Hua Pyong Kang1, Sun Wook Kim1, 
Nam Su Ku1,2, Sang Hoon Han1,2, June Myung Kim1,2, and Jun Yong Choi1,2
1Department of Internal Medicine, and 2AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea
Diffuse large B cell lymphoma (DLBCL) is one of the most common acquired immune deficiency syndrome (AIDS)-defining 
malignancies among human immunodeficiency virus -infected patients, and rectal cancer has recently emerged as a prevalent 
non-AIDS-defining malignancy. We report a case of rectal squamous cell carcinoma that was metachronous with DLBCL in an 
HIV-infected patient who was receiving highly active antiretroviral therapy. The patient was diagnosed with DLBCL and showed 
complete remission after chemotherapy. Follow-up imaging showed increased uptake at the rectum, previously treated as lym-
phoma. Repeated biopsy was performed and squamous cell carcinoma of the rectum was reported. After concurrent chemora-
diation therapy, curative resection was performed.
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Case Report
Introduction
Human immunodeficiency virus (HIV) infection can cause 
defects in cell-mediated immunity, and these defects increase 
the incidence of various malignancies [1]. Acquired immune 
deficiency syndrome (AIDS)-defining malignancies include 
Kaposi’s sarcoma, non-Hodgkin’s lymphoma, primary central 
nervous system lymphoma, and invasive cervical cancer [2]. 
Highly active antiretroviral therapy (HAART) has led to a dra-
matic decrease in AIDS-related mortality as well as the inci-
dence of opportunistic infections and AIDS-defining malig-
nancies [3]. However, many cancers not previously identified 
as AIDS-defining malignancies are now emerging as import-
ant causes of death in persons living with HIV [4-6]. Such 
non-AIDS-defining malignancies include anal, liver, skin, and 
other cancers. 
The mechanisms underlying increased cancer risk are not 
completely understood. An increased prevalence of oncogen-
ic viral coinfection can explain the higher incidence of partic-
ular cancers such as liver, cervical, and anal cancer, as well as 
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non-Hodgkin’s lymphoma.
In South Korea, there are no clear patterns in the relative in-
crease of non-AIDS-defining malignancies and the reduction 
of AIDS-defining malignancies after HAART [7, 8]. Non-Hod-
gkin’s lymphoma is most frequently observed in AIDS-defin-
ing malignancies, and gastrointestinal malignancies are com-
mon among non-AIDS-defining malignancies [8]. Although 
men who have sex with men (MSM) are at highest risk for HIV 
acquisition in South Korea, the anal cancers associated with 
HPV infection are rarely reported. The concurrence of 
non-Hodgkin’s lymphoma and squamous cell carcinoma in 
the rectum in HIV-infected MSM has not been reported yet.
We report a case of rectal squamous cell carcinoma that oc-
curred with metachronous diffuse large B cell lymphoma in 
an HIV-infected MSM.
Case Report
A 51-year-old homosexual male with 10-year history of HIV 
infection presented to the emergency department with com-
plaints of repeated bloody stool (three instances). He had re-
ceived HAART, but his HAART treatment regimen had to be 
altered several times due to adverse events, poor adherence 
and virologic failure. He was taking lamivudine, stavudine, 
lopinavir-ritonavir and abacavir at the time of admission. He 
had no history of opportunistic infections since his diagnosis 
in 1997. He denied any symptoms, including fevers, chills, 
night sweats or weight loss, except hematochezia. On physical 
examination, the abdomen was soft and there were no palpa-
ble masses or tenderness. He had a notable mass on digital 
rectal examination. His CD4+ T cell count was 116/mm3, and 
his HIV viral load was 2,730 copies/mL. Epstein Barr virus 
(EBV) polymerase chain reaction (PCR) showed 27,750 cop-
ies/mL. Sigmoidoscopy demonstrated a 75% circumferential 
ulceroinfiltrative lesion in the rectum and a biopsy was per-
formed (Fig. 1A). Pathologic diagnosis was diffuse large B-cell 
lymphoma with CD20 (+), CD3 (-), cytokeratin (-), and Ki-67 
(90%) (Fig. 1B and C). The staging work-up including a bone 
marrow study revealed lymphoma of the anorectum, naso-
pharynx, upper neck lymph node, and bone marrow with Ann 
Arbor stage IV in July 2007. Chemotherapy was initiated with a 
regimen of rituximab combined with etoposide, vincristine, 
doxorubicin, cyclophosphamide, and prednisone for 4 cycles, 
and vincristine, doxorubicin, cyclophosphamide, and for 2 cy-
cles. The patient achieved complete remission in February 2008.
Figure 1. (A) 75% circumferential ulceroinfiltrative lesion in the rectum. (B) H&E stain (×400): Diffuse large B-cell lymphoma. (C) Immunohistochemical 
stain: CD 20 positive. 
A B C
Figure 2. (A) Ulcerative polypoid lesion in the rectum. (B) H&E stain (×200): Squamous epithelial dysplasia, high grade. (C) H&E stain (×400): Squa-
mous cell carcinoma.
A B C
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Positron emission tomography-computed tomography per-
formed in December 2011 showed higher fluorodeoxyglucose 
uptake in the rectum. In January 2012, a sigmoidoscopy and bi-
opsy were performed and the pathologic diagnosis was high-
grade squamous epithelial dysplasia (Fig. 2A and B). There was 
no continuity between rectal lesion and anal epithelium. At that 
time, the patient’s HIV viral load titer was 80 copies/mL, and his 
CD4+ T cell count was 312/mm3 with a regimen of lamivu-
dine-abacavir, darunavir, ritonavir and etravirine. Well-differen-
tiated squamous cell carcinoma could not be ruled out and the 
clinical stage was T2N1M0, IIIA. Concurrent chemoradiation 
therapy was initiated with 5-fluorouracil and mitomycin C. After 
treatment, there was no evidence of disease. 
In February 2013, follow-up sigmoidoscopy showed a re-
curred mass in the rectum. Well-differentiated squamous cell 
carcinoma was diagnosed with sigmoidoscopic biopsy and 
the patient was treated with laparoscopic-assisted abdomino-
perineal resection (Fig. 2C); the pathologic stage was deter-
mined to be T2N0M0, I. The patient continued to visit the out-
patient department after discharge without significant 
complaint or sign of recurrence.
Discussion
In the past, opportunistic infection was the main cause of 
death in HIV-infected patients; however, with the advent of 
HAART, HIV-infected patients are surviving for much longer 
and instead are facing chronic diseases such as cardiovascular 
disease, liver disease, and cancer [6]. HAART has led to a great 
decrease in the incidence of opportunistic infections and 
AIDS-defining malignancies [3]. In the HAART era, we can as-
sume a decrease in the proportion of AIDS-defining malignan-
cies, but an increase in non-AIDS-defining malignancies [9, 10]. 
In South Korea, there has been no evidence of change in the 
incidence of AIDS-defining malignancies or non-AIDS-defin-
ing malignancies [7, 8]. Seol et al. investigated the prevalence 
of malignancies in HIV-infected patients, and reported similar 
incidence of AIDS-defining and non-AIDS-defining malignan-
cies during the pre-HAART and HAART period, respectively  [8]. 
Cancer occurred in 27 (4%) out of 683 HIV-infected persons. 
Choe et al. reported approximately the same prevalence with 
cancer occurring in 33 patients (3.75%) out of 850 patients [7]. 
Choe et al. did not draw any conclusion about whether the in-
cidence of AIDS-defining malignancies decreased after 
HAART, however, because of the small size of the study popu-
lation. Two studies from South Korea showed only 3 rectal ad-
enocarcinoma cases among 59 HIV-infected patients with 
malignancies [7, 8]. One anal squamous cell carcinoma was 
reported but rectal squamous cell carcinoma was not report-
ed.
The majority of colorectal malignancies both in the general 
population and among HIV-infected patients are adenocarci-
nomas. However, higher proportions of other cancer histologies 
were identified unlike those seen in the general population [11]. 
Compared to the general population, more HIV-infected pa-
tients were diagnosed with squamous cell carcinoma (2.5% vs. 
0.04%, respectively), small cell carcinoma (1.6% vs. 0.08%, re-
spectively), and leiomyosarcoma (0.9% vs. 0.04%, respectively). 
HIV infection increases susceptibility to virally promoted 
cancers such as Burkitt’s lymphoma and Hodgkin’s lymphoma 
(EBV infection), Kaposi’s sarcoma (human herpesvirus-8 [HHV-
8] infection), and anogenital carcinoma (HPV infection) [12]. 
Several HPV types have been known as the oncogenic agents 
responsible for the cervical squamous carcinomas. Molecular 
mechanisms for HPV-associated carcinogenesis have been de-
scribed, mediated by HPV E6 and E7 oncoproteins [13]. Recent 
studies reported that the most common HPV type detected in 
anal squamous cell carcinoma is HPV 16, but non HPV 16 sub-
types were also detected [11, 14, 15]. Unfortunately, in this case, 
PCR test for HPV was not performed.
In the present case, the CD4+ T cell count was 116/mm3 at 
DLBCL diagnosis and 312/mm3 at squamous cell carcinoma 
diagnosis, respectively. A CD4+ T cell count below 200/mm3 
was reported to have a meaningful relationship with the oc-
currence of malignancy in Choe’s study [7]. There was an in-
crease in the proportion of patients with CD4+ T cell counts 
above 200/mm3, which emphasizes the risk of malignancy, 
even in the context of immune reconstitution [16]. It is clear 
that the importance of early diagnosis and prevention of can-
cer in HIV-infected patients should be emphasized.
Non-AIDS-defining malignancy such as HPV-associated 
anorectal cancer is an emerging problem for HIV-infected 
persons in South Korea. The screening and prevention of can-
cers should be included in the clinical care of HIV-infected in-
dividuals.  
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